FreeGulliver LLC
PFE icon

FreeGulliver LLC’s Pfizer PFE Stock Holding History

FreeGulliver LLC’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-8,360
Closed -$201K – 122
2026
Q2 		$201K Buy
+8,360
New +$219K 0.07% 115
2025
Q3 		– Sell
-15,451
Closed -$375K – 114
2025
Q2 		$375K Sell
15,451
-175
-1% -$4.08K 0.17% 57
2025
Q1 		$396K Buy
15,626
+104
+0.7% +$2.72K 0.2% 52
2024
Q4 		$412K Sell
15,522
-840
-5% -$22.8K 0.2% 48
2024
Q3 		$474K Buy
16,362
+708
+5% +$20.7K 0.28% 41
2024
Q2 		$438K Buy
15,654
+114
+0.7% +$3.14K 0.3% 37
2024
Q1 		$431K Hold
15,540
– – 0.38% 31
2023
Q4 		$447K Buy
+15,540
New +$470K 0.59% 21

Other funds holding PFE

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $142B AUM 43.93% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

FreeGulliver LLC's PFE Position: Q3 2026 in Review

FreeGulliver LLC sold out of Pfizer (PFE) in Q3 2026, closing a stake of 8,360 shares — an estimated $201K sold.

FreeGulliver LLC first reported a position in PFE in Q4 2023 and held it in 8 quarters. The position peaked at $474K in Q3 2024. 2,277 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • FreeGulliver LLC reported no remaining Pfizer position as of Q3 2026 after selling out during the quarter.
  • FreeGulliver LLC sold 8,360 Pfizer shares in Q3 2026, an estimated $201K.
  • FreeGulliver LLC first reported a position in Pfizer in Q4 2023 and held it in 8 quarters.
  • FreeGulliver LLC's Pfizer position peaked at $474K in Q3 2024.
  • 2,277 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on FreeGulliver LLC's 13F filing for Q3 2026, filed 10 Nov 2026.